https://www.law360.com/lifesciences?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Life Sciences Copyright 2026 Portfolio Media, Inc. en-US Tue, 26 May 2026 18:47:29 +0000 https://www.law360.com/lifesciences/articles/2482017?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2482017 The Delaware Chancery Court this past week handled a broad mix of cross-border corporate control disputes, merger settlements, startup equity fights, advancement claims and board oversight litigation, while also weighing fallout from high-profile deals involving Microsoft Corp., The Boeing Co. and Nikola Corp. Tue, 26 May 2026 17:40:40 +0000 https://www.law360.com/lifesciences/articles/2481906?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2481906 The Ninth Circuit on Tuesday partially upheld a lower court's preliminary injunction and class certification orders in litigation from University of California researchers against President Donald Trump, backing the reinstatement of grants terminated due to presidential orders against diversity, equity and inclusion initiatives while reversing the injunction for those grants that were rescinded without explanation. Tue, 26 May 2026 17:16:01 +0000 https://www.law360.com/lifesciences/articles/2481724?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2481724 Wholesale distributors that abide by Connecticut's drug price cap law can hike the cost of their other products to ensure they don't suffer losses, the state told the Second Circuit Tuesday, raising the ire of the companies trying to invalidate the new statute. Tue, 26 May 2026 16:20:18 +0000 https://www.law360.com/lifesciences/articles/2481621?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2481621 A New Jersey federal judge affirmed the Beasley Allen Law Firm's disqualification from multidistrict litigation over Johnson & Johnson's talcum powder on Tuesday, determining that the firm has failed to provide a valid reason to back its attempt at a stay and temporary reinstatement into the matter. Tue, 26 May 2026 16:14:25 +0000 https://www.law360.com/lifesciences/articles/2481351?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2481351 U.S. Patent and Trademark Office Director John Squires has created a record low institution rate at the Patent Trial and Appeal Board, and attorneys say it's becoming increasingly clear that even an initial approval from the director may not last. Tue, 26 May 2026 15:29:21 +0000 https://www.law360.com/lifesciences/articles/2481656?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2481656 Eli Lilly and Co. said Tuesday it will buy three companies involved in vaccine development — Curevo Inc., LimmaTech Biologics AG, and Vaccine Company Inc. — for a total of up to roughly $3.83 billion. Mon, 25 May 2026 20:01:25 +0000 https://www.law360.com/lifesciences/articles/2470226?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2470226 This past year, 10 lawyers across the country at plaintiffs' firms big and small helped secure millions of dollars in settlements and verdicts for their clients, going up against powerful defendants like Google, Monsanto and the Trump administration, earning the attorneys recognition as Law360's Titans of the Plaintiffs Bar for 2026. Fri, 22 May 2026 21:56:48 +0000 https://www.law360.com/lifesciences/articles/2481425?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2481425 A University of Toronto marketing professor on Friday told a Los Angeles jury considering bellwether claims that Johnson & Johnson's talc products caused deadly ovarian cancer in three women that the company advertised its talc as "pure" and safe even though its leaders fretted for decades that it could pose health risks. Fri, 22 May 2026 19:16:17 +0000 https://www.law360.com/lifesciences/articles/2481061?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2481061 The U.S. solicitor general's position that the nation's highest court shouldn't take up a religious bias suit over a New York state COVID-19 vaccine mandate for healthcare workers incorrectly claimed that accommodations were obtainable, the mandate's challengers told the justices Friday. Fri, 22 May 2026 18:47:11 +0000 https://www.law360.com/lifesciences/articles/2481132?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2481132 Professional organizations representing nurses, therapists, public health workers and educators urged a District of Columbia federal court on Thursday to block a rule by the U.S. Department of Education restricting federal student loan eligibility for a host of degree programs, arguing it exceeded the department's authority. Fri, 22 May 2026 18:19:39 +0000 https://www.law360.com/lifesciences/articles/2481138?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2481138 A group of plaintiffs in multidistrict litigation against McKinsey & Co. is urging a California federal court to sanction the company for deleting communications with Purdue Pharma and other opioid-makers, saying the court should enter a default judgment against the consulting firm. Fri, 22 May 2026 16:19:24 +0000 https://www.law360.com/lifesciences/articles/2481299?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2481299 A lot can happen in the world of mergers and acquisitions and equity fundraising over the course of a couple of weeks, and it's difficult to keep up with all the deals. Fri, 22 May 2026 16:16:56 +0000 https://www.law360.com/lifesciences/articles/2479552?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2479552 The Justice Department’s recent lowering of certain medical marijuana products to Schedule III means operators — particularly those simultaneously offering federally illegal adult-use cannabis — must implement greater structural discipline to navigate an increasingly fragmented legal landscape if they hope to benefit from new tax deductions and access to capital, say attorneys at Akerman. Fri, 22 May 2026 12:06:45 +0000 https://www.law360.com/lifesciences/articles/2480674?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2480674 A Colorado dietary supplement company accused of bombarding consumers with unsolicited telemarketing texts has been let off the hook after the woman who sued it voluntarily dropped the case, according to a filing in Colorado federal court. Fri, 22 May 2026 11:56:49 +0000 https://www.law360.com/lifesciences/articles/2479608?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2479608 Environmental initiatives, diversity programs, anti-misinformation efforts and gender-affirming care have become central targets for President Donald Trump's antitrust enforcers in what observers say is an increasing trend of politically tinged competition enforcement. Thu, 21 May 2026 21:55:43 +0000 https://www.law360.com/lifesciences/articles/2480818?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2480818 Pharmacy benefit manager Prime Therapeutics LLC has replaced counsel Cravath Swaine & Moore LLP with WilmerHale and another firm in an antitrust case in Michigan federal court brought by the state's attorney general. Thu, 21 May 2026 21:41:30 +0000 https://www.law360.com/lifesciences/articles/2480894?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2480894 Johnson & Johnson used an ellipsis to eliminate a professor's finding of asbestos in its talc in a report submitted to the U.S. Food and Drug Administration, according to a video deposition shown Thursday to a California jury considering bellwether claims over three women's deadly ovarian cancer. Thu, 21 May 2026 21:32:45 +0000 https://www.law360.com/lifesciences/articles/2480863?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2480863 A Ninth Circuit panel scrapped a ruling that directed the U.S. Environmental Protection Agency to take action to address potentially unsafe levels of drinking water fluoridation, concluding a California federal judge improperly commandeered the case. Thu, 21 May 2026 21:11:29 +0000 https://www.law360.com/lifesciences/articles/2479999?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2479999 Two reported NFL stake sales this past week highlight the continued surge in professional sports valuations, fueled in part by the entry of private equity investors. Thu, 21 May 2026 21:11:28 +0000 https://www.law360.com/lifesciences/articles/2480608?utm_source=rss&utm_medium=rss&utm_campaign=section https://www.law360.com/lifesciences/articles/2480608 A North Carolina federal judge found that a life sciences company's insurer can't avoid counterclaims brought by a former patent holder asserting that the carrier must cover a $1.77 million judgment entered against the company's executives after they were accused of making misrepresentations about taking the company public.